Risperdal Side Effects
The U.S. Food and Drug Administration (FDA) approved Risperdal for the treatment of schizophrenia in 2002 and for the short-term treatment of acute mania and Bipolar Disorder in 2003. However, Janssen Pharmaceuticals has marketed the drug for off-label uses including as a treatment for attention-deficit/hyperactivity disorder (ADHD). Off-label marketing, and use, of a prescription means that the drug has not been approved by the FDA for that particular purpose and is a violation of the law. Risperdal can increase the amount of the hormone, prolactin, in the body. Prolactin stimulates milk production in women during pregnancy.
Please call our firm today if you or a loved one has taken Risperdal and experienced any of the following:
- Gynecomastia (male breast growth)
- Swelling/painful breasts
AFFECTED BY RISPERDAL?
Call Now! 1-800-366-6577
Risperdal News and Updates
- J&J’s Janssen Pharmaceuticals Under Fire Again in Risperdal Trial
Johnson & Johnson’s Janssen Pharmaceuticals came under fire again when a Philadelphia jury awarded $70 million to the family of a boy who developed breasts while taking the company’s antipsychotic drug Risperdal. Apparently the jury found that Janssen intentionally falsified, destroyed or concealed evidence in the case in reaching its ...
- Jury Awards $70 Million in Risperdal Trial
In early July, a jury in a Philadelphia courtroom awarded $70 million to the family of a boy who developed breasts after taking the antipsychotic drug Risperdal. The jury found that the maker of Risperdal, Janssen Pharmaceuticals, failed to warn the boy’s healthcare providers that there was a risk of ...
- Troubling Allegations in Risperdal Trial
The most troubling aspect of a recent case decided against Johnson & Johnson (J&J) concerning its antipsychotic drug Risperdal is the allegation that the company deliberately withheld data from the U.S. Food and Drug Administration. An expert witness testified that J&J knew about the risk of gynecomastia associated with Risperdal ...
- Jury Awards $2.5 Million in Risperdal Trial
The Wall Street Journal reported that a Philadelphia jury held Johnson & Johnson (J&J) liable for failing to warn that its antipsychotic drug Risperdal could cause gynecomastia and ordered the company to pay $2.5 million in damages. The family of an autistic boy who took Risperdal between 2002 and 2006 ...
Are You Eligible for a Risperdal Lawsuit?
The Feeney Law Firm is committed to seeking justice for those inflicted with gynecomastia as a result of Risperdal use. Fighting to keep people safe from corporate greed and self-interest is our passion. We are here to help make that process as simple as possible for you and your family. Call us now at 1-800-366-6577 for a FREE consultation. Don’t wait; your time to file a Risperdal lawsuit may be limited.
Do not stop taking these drugs without first speaking to your doctor.